US domestic manufacturing investment, R&D model shifts, new excipients, and digital traceability are redefining drug ...

The new partnership will work to embed digital identification into labware, solving chain-of-identity challenges for ...

For pharmaceutical manufacturers, the most immediate and critical application of RWE is in monitoring post-market safety. The ...

In episode 27, Christopher Hopkins, PhD; Omkar Kawalekar, PhD; Barnaby Pickering; and Jerry Rosenbaum, MD, go behind the ...

Oral and inhaled biologics are gaining R&D investment due to patient acceptance and potential for home administration, with ...

At CPHI and AAPS, Ashland plans to detail the impacts of its advanced excipients: ultra-low nitrite materials curb ...

The first needle-free adrenaline treatment launches in the UK, validating non-invasive delivery with real-world data ...

Major pharmaceutical investments in the United States are expanding API, capsule, and packaging capacity, enhancing supply chain resilience and supporting domestic drug production.

John B. Kowalski, PhD, is principal consultant of SteriPro Consulting at Sterigenics International, Inc., in Oak Brook, IL.